Tenaris SA (TW10) News

Directa Plus CEO Giulio Cesareo talked with Proactive's Stephen Gunnion about the company’s strong start to 2025 and the strategic impact of its environmental operations. Cesareo shared that the company saw a 40% rise in first-quarter revenue to approximately €2 million, driven by new contracts in Romania and a recovering textile market in Italy. “We have a significant contract with Midia International,” Cesareo explained, adding that work on oil recovery from drilling platforms resumed after a slowdown in 2024 due to the war in the Black Sea. The full acquisition of Setcar, a Romanian environmental service company, plays a central role in the company’s strategy. Cesareo highlighted that Setcar not only holds a full suite of environmental certifications but also occupies a “geopolitical significant position” as a potential gateway to Ukraine’s reconstruction. Environmental applications remain a key focus for Directa Plus, especially the use of its graphene materials to decontaminate water and soil. In collaboration with OMV Petrom, the company successfully decontaminated 44,000 cubic meters of water, recovering 10,000 barrels of crude oil. Research and development are also advancing. Directa Plus is working with Nant G Power on battery materials and refocusing on opportunities in sectors like tyres and PFAS filtration. Cesareo stated, “There are significant opportunities, despite the actual crisis, that can be captured by our innovative material.” With €4 million in cash and a burn rate that extends funding through to August 2026, Cesareo believes the company is well-positioned for the year ahead. For more exclusive interviews and updates, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and enable notifications to stay up to date. #DirectaPlus #GrapheneTechnology #EnvironmentalSolutions #Setcar #OilRecovery #PFAS #CleanTech #NantGPower #UkraineReconstruction #TextileInnovation #BatteryMaterials #Q12025 #InvestingInGraphene #Proa

Oriole Resources PLC (AIM:ORR) CEO Martin Rosser talked with Proactive's Stephen Gunnion about the latest drilling results from the company’s maiden drilling programme at the Mbe project in Cameroon. Rosser said the newly announced results are in line with previous findings, noting “multiple intersections of gold mineralisation over good widths.” These results support the emerging geological model, as the company continues to build a 3D picture of the deposit. According to Rosser, the mineralisation observed so far points to the potential for a bulk tonnage, open pit mineable operation—an outcome he noted is attractive for major mining companies seeking scale efficiencies. He added that Oriole is on track to complete the drilling program by the third quarter of this year. Following that, the company expects to publish both a maiden mineral resource estimate and an exploration target during the second half of the year. Regular updates on further drill results are anticipated as assays are returned and validated. Rosser also encouraged stakeholders to attend an investor presentation and Q&A scheduled for 13:00, offering more insight into the company’s progress and plans. Follow this link for details: https://polaris.brighterir.com/public/oriole_resources/news/regulatory_news/story/wk6v3dx Visit Proactive's YouTube channel for more videos. Don’t forget to give this video a like, subscribe to the channel, and enable notifications for future content. #OrioleResources #GoldExploration #CameroonMining #MbeProject #JuniorMining #GoldDrilling #MineralExploration #OpenPitMining #MiningInvestors #ProactiveInvestors

SSV Capital PLC CEO Ankur Ghosh talked with Proactive about the company’s early loan repayment, expansion in fintech and real estate, and upcoming plans for 2025. SSV Capital has made strides in solidifying its financial position, having repaid a £2.5 million convertible loan note ahead of schedule. Ghosh attributed the decision to strong investor trust and confidence in the company’s banking and fintech operations. “If our balance sheet is strong, why can’t we repay them early?” he stated, highlighting the company's proactive approach even in a challenging financial climate. Ghosh also discussed momentum behind SSV Smart Pay, noting positive reception from both merchants and customers and ambitious targets of scaling to 2 million transactions this year. The initiative incorporates loyalty and cashback schemes and is underpinned by open banking and upcoming embedded finance capabilities. In addition, SSV Capital is progressing in its Proptech development through its SSV Real Estate unit. Ghosh explained that the project has passed alpha and beta testing and is now on track to roll out in the coming months. Looking ahead, the company is focusing on institutional partnerships, establishing a presence as a general partner in Luxembourg, and pursuing FCA licenses as it builds out an equity desk focused on early-stage private equity and venture capital. Visit Proactive's YouTube channel for more insightful interviews and updates. Don't forget to give the video a like, subscribe to the channel, and enable notifications for future content. #SSVCapital #AnkurGhosh #SmartPay #Fintech #OpenBanking #EmbeddedFinance #RealEstateTech #Proptech #PrivateEquity #VentureCapital #FinancialServices #InstitutionalInvestment #InvestorUpdates #FCA #LuxembourgFunds

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the company’s new strategic partnership with US-based Heureka Labs, a spinoff of Duke University, to enhance its gene therapy research using AI technology. Leire said: “Every biotech in gene therapy should have an AI component. If you don't have that, you miss a critical tool to unlock value for your shareholders.” He stressed the need for a multi-omics approach—genomic, transcriptomic, and proteomic—to better understand gene expression and drug response, which traditional analysis methods struggle to fully capture. The partnership with Heureka Labs, which integrates deep AI and biological expertise, will initially support Genflow’s lead candidate, GF-1002, a SIRT-6 gene therapy targeting MASH (metabolic dysfunction-associated steatohepatitis). AI will help the company analyse complex preclinical data, including insights from nearly 700 mice tested, to understand mechanisms of action and identify likely responders—crucial in discussions with regulators such as the FDA and EMA. Leire also emphasised that the collaboration is scalable across Genflow’s pipeline, helping unlock synergies between programmes in liver, muscle, and eye diseases. For more interviews like this, visit Proactive’s YouTube channel. Don’t forget to give this video a like, subscribe to the channel, and enable notifications for future content. #GenflowBiosciences #GeneTherapy #AIinBiotech #BiotechNews #MASH #SIRT6 #HeurekaLabs #DrugDevelopment #MultiOmics #BiotechPartnership #FDA #EMA #PreclinicalResearch